GLP-1 Skin Is Real — Here’s How Dermatologists Are Treating It
Rapid weight loss can transform your health, energy, and metabolic markers. But for many people taking GLP-1 medications like Ozempic, Wegovy, Mounjaro, or Zepbound, there’s an unexpected side effect that often shows up in the mirror first: thinner, drier, more hollow-looking skin.
Dermatologists are increasingly referring to this as “GLP-1 skin” — a combination of volume loss, skin laxity, dehydration, and accelerated collagen decline that can happen after significant medication-driven weight loss.
Now, emerging research suggests that regenerative treatments may help address these changes more effectively than traditional fillers alone. A recent study conducted by Dr. Andreas Nikolis[1] examined how combining Sculptra and Restylane Skinboosters improved hydration, skin barrier function, elasticity, and collagen support in menopausal women — and researchers also explored how GLP-1 medications may alter fat tissue itself.
Why GLP-1 Skin Happens
Most people assume the issue is simply “losing fat in the face.” But researchers are beginning to think the biology is more complicated. In interim data presented this spring, investigators found that patients experiencing medication-driven weight loss showed a significant reduction in adipose-derived stem cells — cells involved in tissue regeneration and structural support.[2]
That may help explain why some people notice: hollow cheeks and temples, crepey or loose skin, increased dryness, more visible wrinkles, sagging around the jawline, and skin that suddenly looks “tired” or deflated. The changes can resemble what happens during menopause, when estrogen decline contributes to rapid collagen loss, thinning skin, and impaired barrier function.
The New Approach: Hydration + Collagen Stimulation
For years, aesthetic medicine focused heavily on replacing lost volume with filler. But many dermatologists now believe GLP-1 skin requires a broader regenerative approach. That’s where treatments like Restylane Skinboosters and Sculptra come in.
Restylane Skinboosters: Rehydrating the Skin
Restylane Skinboosters use hyaluronic acid to improve hydration, smoothness, and skin quality rather than creating dramatic volume. Think of it as improving the condition of the skin itself instead of simply “filling” it. In the recent menopause-focused trial, patients who received Restylane Skinboosters first experienced the greatest improvement in hydration and barrier function. For GLP-1 patients, that matters because rapid weight loss often leaves skin looking dehydrated and fragile before volume loss becomes severe.
Sculptra: Rebuilding Collagen Over Time
Sculptra works differently from traditional fillers. Instead of instantly filling space, it stimulates the body to gradually produce collagen over several months. That slow collagen remodeling may be particularly useful for people experiencing diffuse facial thinning, crepey texture, skin laxity, and structural collagen decline.
Researchers noted that regenerative treatments like Sculptra may align better with the biology of medication-driven weight loss because the issue may involve tissue regeneration — not just fat depletion.
Why Combination Treatment Matters
One of the most interesting findings from the new data is that sequencing appears important. The combination approach worked best when hydration was restored first, followed by collagen stimulation later. That mirrors what many cosmetic dermatologists already see clinically: rehydrate the skin; improve barrier function; stimulate collagen gradually; and restore structure conservatively. This tends to create more natural-looking results than aggressively adding filler to an already dehydrated face.
Other Treatments That May Help GLP-1 Skin
Injectables are only part of the picture. Dermatologists often combine them with treatments that support collagen production and skin quality. Common options include:
Microneedling
Creates controlled micro-injury that stimulates collagen remodeling.
Radiofrequency Microneedling
Combines collagen induction with skin tightening.
Prescription Retinoids
Tretinoin remains one of the most evidence-based topical collagen stimulators available.
Growth Factor or Peptide Skincare
Some patients use regenerative skincare products to support healing and elasticity.
Hormonal Evaluation
For peri- and postmenopausal women, hormonal shifts may compound GLP-1-related collagen loss. Some patients report improved skin quality after starting hormone replacement therapy, although treatment should always be individualized medically.
What Dermatologists Want Patients to Understand
The biggest misconception about GLP-1 skin is that more filler is automatically the answer.
In reality, overfilling can sometimes worsen the problem by making the face appear puffy while skin quality remains thin and dehydrated. The goal is not to erase weight loss — it’s to help the skin adapt to it. Many experts now favor a regenerative strategy focused on collagen support, hydration, gradual restoration, and skin health first.
The Bottom Line
GLP-1 medications are changing medicine and helping millions improve their health. But rapid weight loss can expose underlying collagen loss, skin thinning, and structural changes faster than the skin can naturally recover. Emerging research suggests the future of treatment may combine: hydration-focused injectables like Restylane Skinboosters; regenerative collagen stimulators like Sculptra; energy-based tightening treatments; medical-grade skincare; individualized hormonal and nutritional support; and, more importantly, dermatologists are beginning to treat GLP-1 skin as a biologic process — not just a cosmetic concern.
Sources
[1] Nikolis A, et al. A comprehensive interim analysis of skin hydration, barrier function (TEWL), elasticity, and patient satisfaction across two treatment arms. Interim Data on File. Galderma. April 2026
[2] Fabi S, et al. Investigating the Impact of GLP-1 Receptor Agonists on Adipose-Derived Stem Cells. Interim Data on File. Galderma. April 2026
Galderma
Interim data from two ongoing investigator-initiated trials highlight the role of Sculptra® and Restylane® in addressing aesthetic changes associated with weight loss medications and menopause | Galderma. April 8, 2026
Dermatology Times
Galderma Unveils New Interim Trial Data on Menopause and Weight Loss-Driven Skin Changes | Dermatology Times
reachmd.com
Interim IIT Data Explore Sculptra, Restylane for Menopause, Weight Loss–Related Aesthetic Changes – Be part of the knowledge – ReachMD
CenterWatch
Post-Menopause Skin Rejuvenation Study | Clinical Research Trial Listing. January 19, 2026
ICHGCP
Sculptra Aesthetic and Restylane SkinBoosters Vital in Menopause and Post-menopause and Hyaluronic Acid – Clinical Trials Registry – ICH GCP
MedEsthetics
New Dual-Sequence Menopause Study Shows Skin Quality Improvement With Restylane Skinboosters and Sculptra | MedEsthetics. April 12, 2026





















